Cancer Drug

Diplomat Specialty Pharmacy

Diplomat Receives Limited Distribution Contract For Cancer Drug

Diplomat, the country’s largest independent specialty pharmacy, announced it is one of five specialty pharmacies selected as a provider of Imbruvica (ibrutinib) capsules, approved Nov. 13 by the U.S. Food and Drug Administration for the treatment of mantle cell lymphoma.

WWJ Newsradio 950–11/14/2013

A scanning electron microscope picture of a cancer cell. Uncredited photo from Wikimedia Commons

Ann Arbor Startup Starts Human Trial Of Adrenal Cancer Drug

A startup biotech company has started a Phase 1 human clinical trial of a drug to treat a rare form of cancer.

WWJ Newsradio 950–10/15/2013

ProNAi

ProNAi Presents Cancer Drug Results, Expands Management Team

ProNAi Therapeutics Inc., a cancer drug development company, said last week that it had concluded its initial human clinical trial of PNT2258, a new type of nucleic acid drug.

WWJ Newsradio 950–11/11/2012

Follow

Get every new post delivered to your Inbox.

Join 2,062 other followers